# Meropenem

## (美平)Mepem inj 0.25gm

| TAH Drug Code      | [IMEP2](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IMEP2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Meropenem is used to treat infections caused by bacteria that are susceptible to it, such as Staphylococcus sp., Streptococcus sp., Enterococcus sp., Neisseria meningitidis, Branhamella catarrhalis, E. coli, Citrobacter sp., Klebsiella sp., Enterobacter sp., Serratia sp., Proteus sp., Pseudomonas sp., Haemophilus influenzae, and Bacteroides sp. These infections include: - Sepsis - Cellulitis, lymphadenitis - Tonsillar abscess - Perianal abscess - Osteomyelitis - Trauma, burns, and surgical infections - Chronic bronchitis, bronchiectasis (with infection), secondary infections of chronic respiratory diseases, pneumonia, lung abscess, empyema - Pyelonephritis, complicated cystitis - Cholecystitis, cholangitis, liver abscess - Peritonitis - Infections of the adnexa, intrauterine infections, pelvic inflammatory disease, parametritis - Purulent meningitis - Endophthalmitis - Otitis media, sinusitis - Temporomandibular arthritis, perioral cellulitis                                                        |
| Dosing             | Adults: 0.5-2 g in 2-3 divided doses IV infused over 30 minutes. Children: 30-120 mg/kg in 2-3 divided doses IV infused over 30 minutes (max. 2 g/day). *****NEONATE ANTIBIOTICS DOSE***** Meropenem: general infection Body weight <1kg ge<=7day 20mg/kg Q12H  Age 8-14 day 20mg/kg Q12H  Age 15-28 day 20 mg/kg Q8H Body weight 1-2kg ge<=7day 20mg/kg Q12H  Age 8-14 day 20 mg/kg Q8H  Age 15-28 day 20 mg/kg Q8H Body weight >2kg Age<=7day 20 mg/kg Q8H  Age 8-14 day 30 mg/kg Q8H  Age 15-28 day 30mg/kg Q8H meningitis Body weight <1kg ge<=7day 40mg/kg Q12H  Age 8-14 day 40mg/kg Q12H  Age 15-28 day 40 mg/kg Q8H Body weight 1-2kg ge<=7day 40mg/kg Q12H  Age 8-14 day 40 mg/kg Q8H  Age 15-28 day 40 mg/kg Q8H Body weight >2kg Age <=7ayd 40 mg/kg Q8H  Age 8-14 d ay 40 mg/kg Q8H  Age 15-28 day 40mg/kg Q8H                                                                                                                                                                                                                          |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Contraindications  | (1) Patients with a history of anaphylactic shock to the ingredients of this product. (2) Patients using Sodium Valproate. (3) As a general rule, should not be used in patients with a history of allergies to the ingredients of this product. If necessary due to special circumstances, the medication should be used with caution.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Adverse Effects    | Shock, serious renal disorders including acute renal failure, serious colitis accompanied with bloody stool, pseudomembranous colitis, interstitial pneumonia & PIE syndrome. CNS convulsion e.g. seizures, consciousness disorders. Lyell syndrome, Steven-Johnson syndrome, pancytopenia, agranulocytosis, leucopenia, hepatic disorders, jaundice, rash, urticaria, feeling of warmth, erythema, pruritus, fever & redness. Granulocytopenia, eosinophilia, thrombocytopenia or thrombocytosis & lymphocytosis increased GOT/GPT/LDH/A1-P/LAP/γ-GTP/bilirubin/urinary urobilinogen, decreased cholinesterase, increased urinary β2-microglobulin/BUN/creatinine, abdominal pain, diarrhea, nausea, vomiting & anorexia, stomatitis, candidiasis, vit K deficiency symptoms, vit B complex deficiency symptoms, headache, malaise. Dermatologic: Injection site inflammation (2.4% ) Gastrointestinal: Constipation (1.4% to 7% ), Diarrhea (3.5% to 7% ), Nausea and vomiting (3.6% adults; 0.8% children ) Neurologic: Headache (2.3% to 7.8% ) |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| More Info          | [UpToDate](https://www.uptodate.com/contents/meropenem-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |

